Skip to main content
Have a personal or library account? Click to login
RLIP76 Gene Variants are not Associated with Drug Response in Turkish Epilepsy Patients Cover

RLIP76 Gene Variants are not Associated with Drug Response in Turkish Epilepsy Patients

Balkan Journal of Medical Genetics
Volume 14 (2011): Issue 1 (June 2011)
By: ,  ,  ,  ,  ,  ,  ,   and    
Open Access
|Jul 2011
References

References

  1. Sillanpää M, Schmidt D. Natural history of treated childhood-onset epilepsy: prospective, long-term population-based study. Brain. 2006; 129(Pt. 3): 617-624.
    Open DOISearch in Google Scholar
  2. Steinlein OK. Gene polymorphisms and their role in epilepsy treatment and prognosis. Naunyn Schmiedebergs Arch Pharmacol. 2010; 382(2): 109-118.
    Open DOISearch in Google Scholar
  3. Sisodiya SM, Marini C. Genetics of antiepileptic drug resistance. Curr Opin Neurol. 2009; 22(2): 150-156.
    Open DOISearch in Google Scholar
  4. Awasthi S, Hallene KL, Fazio V, Singhal SS, Cucullo L, Awasthi YC, Dini G, Janigro D. RLIP76, a non-ABC transporter, and drug resistance in epilepsy. BMC Neurosci. 2005; 6: 61.
    Open DOISearch in Google Scholar
  5. Jullien-Flores V, Dorseuil O, Romero F, Letourneur F, Saragosti S, Berger R, Tavitian A, Gacon G, Camonis JH. Bridging Ral GTPase to Rho pathways. RLIP76, a Ral effector with CDC42/Rac GTPase-activating protein activity. J Biol Chem. 1995; 270(38): 22473-22477.
    Open DOISearch in Google Scholar
  6. Awasthi S, Singhal SS, Sharma R, Zimniak P, Awasthi YC. Transport of glutathione conjugates and chemotherapeutic drugs by RLIP76 (RALBP1): a novel link between G-protein and tyrosine kinase signaling and drug resistance. Int J Cancer. 2003; 106(5): 635-646.
    Open DOISearch in Google Scholar
  7. Sharma R, Singhal SS, Cheng J, Yang Y, Sharma A, Zimniak P, Awasthi S, Awasthi YC. RLIP76 is the major ATP-dependent transporter of glutathione-conjugates and doxorubicin in human erythrocytes. Arch Biochem Biophys. 2001; 391(2): 171-179.
    Open DOISearch in Google Scholar
  8. Rossé C, L'Hoste S, Offner N, Picard A, Camonis J. RLIP, an effector of the Ral GTPases, is a platform for Cdk1 to phosphorylate epsin during the switch off of endocytosis in mitosis. J Biol Chem. 2003; 278(33): 30597-30604.
    Open DOISearch in Google Scholar
  9. Singhal SS, Yadav S, Singhal J, Awasthi YC, Awasthi S. Mitogenic and drug-resistance mediating effects of PK-Calpha require RLIP76. Biochem Biophys Res Commun. 2006; 348(2): 722-727.
    Open DOISearch in Google Scholar
  10. Awasthi S, Singhal SS, Yadav S, Singhal J, Vatsyayan R, Zajac E, Luchowski R, Borvak J, Gryczynski K, Awasthi YC. A central role of RLIP76 in regulation of glycemic control. Diabetes. 2010; 59(3): 714-725.
    Open DOISearch in Google Scholar
  11. Soranzo N, Kelly L, Martinian L, Burley MW, Thom M, Sali A, Kroetz DL, Goldstein DB, Sisodiya SM. Lack of support for a role for RLIP76 (RALBP1) in response to treatment or predisposition to epilepsy. Epilepsia. 2007; 48(6): 674-683.
    Open DOISearch in Google Scholar
  12. Leschziner GD, Jorgensen AL, Andrew T, Williamson PR, Marson AG, Coffey AJ, Middleditch C, Balding DJ, Rogers J, Bentley DR, Chadwick D, Johnson MR, Pirmohamed M. The association between polymorphisms in RLIP76 and drug response in epilepsy. Pharmacogenomics. 2007; 8(12): 1715-1722.
    Open DOISearch in Google Scholar
  13. Miller SA, Dykes DD, Polesky HF. A simple salting out procedure for extracting DNA from human nucleated cells. Nucleic Acids Res. 1988; 16(3): 1215.
    Open DOISearch in Google Scholar
  14. Alper OM, Erengin H, Manguoğlu AE, Bilgen T, Cetin Z, Dedeoğlu N, Lüleci G. Consanguineous marriages in the province of Antalya, Turkey. Ann Genet. 2004; 47(2): 129-138.
    Open DOISearch in Google Scholar
  15. Janigro D, Awasthi S, Awasthi YC, Sharma R, Yadav S, Singhal SS, Hallene K. RLIP76 in AED drug resistance. Epilepsia. 2007; 48(6): 1218-1219.
    Open DOISearch in Google Scholar
  16. Sisodiya S, Thom M. Response to Janigro et al. Epilepsia. 2007; 48(6): 219-220.
    Open DOISearch in Google Scholar
  17. Löscher W, Klotz U, Zimprich F, Schmidt D. The clinical impact of pharmacogenetics on the treatment of epilepsy. Epilepsia. 2009; 50(1): 1-23.
    Open DOISearch in Google Scholar
  18. Haerian BS, Roslan H, Raymond AA, Tan CT, Lim KS, Zulkifli SZ, Mohamed EH, Tan HJ, Mohamed Z. AB-CB1 C3435T polymorphism and the risk of resistance to antiepileptic drugs in epilepsy: a systematic review and meta-analysis. Seizure. 2010; 19(6): 339-346.
    Open DOISearch in Google Scholar
  19. Zhang C, Kwan P, Zuo Z, Baum L. In vitro concentration dependent transport of phenytoin and phenobarbital, but not ethosuximide, by human P-glycoprotein. Life Sci. 2010; 86(23-24): 899-905.
    Open DOISearch in Google Scholar
  20. Rivers F, O'Brien TJ, Callaghan R. Exploring the possible interaction between antiepilepsy drugs and multi-drug efflux pumps; in vitro observations. Eur J Pharmacol. 2008; 598(1-3): 1-8.
    Open DOISearch in Google Scholar
  21. Luna-Tortós C, Fedrowitz M, Löscher W. Evaluation of transport of common antiepileptic drugs by human multidrug resistance-associated proteins (MRP1, 2 and 5) that are overexpressed in pharmacoresistant epilepsy. Neuropharmacology. 2010; 58(7): 1019-1032.
    Open DOISearch in Google Scholar
  22. Sánchez MB, Herranz JL, Leno C, Arteaga R, Oterino A, Valdizán EM, Nicolás JM, Adín J, Armijo JA. Genetic factors associated with drug-resistance of epilepsy: relevance of stratification by patient age and aetiology of epilepsy. Seizure. 2010; 19(2): 93-101.
    Open DOISearch in Google Scholar
  23. Berg AT. Identification of pharmacoresistant epilepsy. Neurol Clin. 2009; 27(4): 1003-1013.
    Open DOISearch in Google Scholar
  24. Viteva EI, Zahariev ZI. Pseudoresistance in patients with epilepsy characteristics and determining factors. Folia Med (Plovdiv). 2009; 51(2): 33-39.
    Search in Google Scholar
  25. Kim WJ, Lee JH, Yi J, Cho YJ, Heo K, Lee SH, Kim SW, Kim MK, Kim KH, Lee BI, Lee MG. A nonsynonymous variation in MRP2/ABCC2 is associated with neurological adverse drug reactions of carbamazepine in patients with epilepsy. Pharmacogenet Genom. 2010; 20(4): 249-256.
    Open DOISearch in Google Scholar
  26. Canevini MP, De Sarro G, Galimberti CA, Gatti G, Licchetta L, Malerba A, Muscas G, La Neve A, Striano P, Perucca E, and the SOPHIE Study Group. Relationship between adverse effects of antiepileptic drugs, number of coprescribed drugs, and drug load in a large cohort of consecutive patients with drug-refractory epilepsy. Epilepsia. 2010; 51(5): 797-804.
    Open DOISearch in Google Scholar
DOI: https://doi.org/10.2478/v10034-011-0014-3 | Journal eISSN: 2199-5761 (formerly 1311-0160) | Journal ISSN: 1311-0160
Journal RSS Feed
Language: English
Page range: 25 - 30
Published on: Jul 25, 2011
Published by: Macedonian Academy of Sciences and Arts
In partnership with: Paradigm Publishing Services
Keywords:
Epilepsy,
Neuropharmacology,
Pharmacogenetics,
Polymorphism,
RLIP76 gene
Related subjects:
Medicine,
Basic medical science,
Basic medical science, other

© 2011 E Manguoğlu, S Akdeniz, N Dündar, Ö Duman, B Aktekin, Ş Haspolat, U Bilge, D Özel, G Lüleci, published by Macedonian Academy of Sciences and Arts
This work is licensed under the Creative Commons License.

Volume 14 (2011): Issue 1 (June 2011)
Previous article
Next article